PICO Portalanswers from OpenAlex
Yonsei University
InstitutionResearch output, impact & collaborations
Yonsei University is a institution indexed in PICO Portal from OpenAlex.
What is known about Yonsei University?
PICO Portalrecord summary
Yonsei University is a research organisation in Seoul, KR. OpenAlex records 181,416 works and 13,619,837 citations for it. 44,037 researchers list it as their most recent affiliation.
How many works does Yonsei University have?
PICO Portalindexed works
Yonsei University has 181,416 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yonsei University have?
PICO Portalcitation count
Yonsei University has 13,619,837 citations in the OpenAlex counts PICO Portal stores.
How many researchers are at Yonsei University?
PICO Portalresearcher count
Yonsei University has 44,037 researchers in the PICO Portal index.
What is the average h-index at Yonsei University?
PICO Portalavg h-index
Yonsei University has an average h-index of 65.8 in OpenAlex.
What is the ROR of Yonsei University?
PICO Portalror
The ROR for Yonsei University is on the source record.
What is the OpenAlex record for Yonsei University?
PICO Portalopenalex
The OpenAlex for Yonsei University is on the source record.
Who are the most-cited researchers behind Yonsei University?
PICO Portaltop researchers by citations
What are the most-cited papers on Yonsei University?
PICO Portalmost cited works
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L. Baehner, Michael G. Walker, Drew Watson, Taesung Park, W. Douglas B. Hiller, Edwin R. Fisher, D. Lawrence Wickerham, John Bryant, Norman Wolmark
Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer
Jean‐Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata, Isamu Okamoto, Caicun Zhou, Byoung Chul Cho, Ying Cheng, Eun Kyung Cho, Pei Jye Voon, David Planchard, Wu‐Chou Su, Jhanelle E. Gray, Siow Ming Lee, Rachel Hodge, Marcelo Marotti, Yuri Rukazenkov, Suresh S. Ramalingam
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela Klein, James N. Ingle, Norman Wolmark
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P. Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Sandra M. Swain, Tatiana M. Prowell, Sibylle Loibl, D. Lawrence Wickerham, Jan Bogaerts, José Baselga, Charles M. Perou, Gideon M. Blumenthal, Jens‐Uwe Blohmer, Eleftherios P. Mamounas, Jonas Bergh, Semiglazov Vf, Robert Justice, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter A. Fasching, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles E. Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, W. Eiermann, Gϋnter von Minckwitz
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takashi Yokoi, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Catherine Wadsworth, Giovanni Melillo, Haiyi Jiang, Yifan Huang, Phillip A. Dennis, Mustafa Özgüroğlu
How much of the research on Yonsei University is open access?
PICO Portalopen access share
92%OPEN ACCESS